Market by Deployment Mode, Component, Product Type, End-user, and Geography | Forecast 2021-2028
After
a detailed analysis, Triton Market Research’s report on the clinical trial
management market has concluded that the market is expected to display an
upward trend, growing at a CAGR of 10.92 % over the forecast period of 2021 to
2028. In 2020, the market acquired $839.68 million, and is anticipated to reach
revenue worth $1810.09 million by 2028.
Report scope can be customized per your requirements. Request For Customization
Clinical
trial management (CTM) includes hardware, software, and services involved in
maintaining and managing the high complexity and volume of data obtained from
the clinical trials across different organizations and regions. It helps in
process and time optimization, minimizing the communication gap. This has
proved to be a boon for pharmaceutical companies and clinical research
organizations to supervise, maintain, and retrieve data whenever required.
Moreover, this has led to an increase in developmental activities in the life
science industry.
Triton’s
report on the clinical trial management market discusses the market scope and
key insights regarding the market. Also, the market attractiveness matrix,
vendor scorecard, impact of COVID-19 on the market, and Porter’s five forces
analysis, are studied in detail.
Market
drivers such as the rise in chronic diseases, increase in research &
development in the medical sector, and benefits of CTM software stimulate the
growth of the studied market. In addition, the growth in clinical trials,
paired with outsourcing clinical trials for cost reduction, are key
opportunities that the market can leverage to reach its anticipated progress.
However, the concerns relating to the security of the CTM systems, lack of skilled workforce, and high cost of implementation are factors negatively impacting the overall market’s growth.
Major geographies covered in the global clinical
trial management market are:
• North America: United States and Canada
• Europe:
United Kingdom, Germany, France, Italy, Spain, Russia, and Rest of Europe
• Asia-Pacific:
China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand,
and Rest of Asia-Pacific
• Latin America: Brazil, Mexico, and Rest of Latin America
• Middle East and Africa: United Arab Emirates, Turkey, Saudi Arabia, South Africa, and
Rest of Middle East and Africa
The segmentation analysis of the clinical trial
management market includes:
• Market
by Deployment Mode:
o Web-based Deployment
o On-Premise Deployment
o Cloud-based Deployment
• Market
by Component:
o Software
o Hardware
o Services
• Market
by Product Type:
o Enterprise-based CTM
o Site-based CTM
• Market
by End-user:
o Pharmaceutical &
Biopharmaceutical Companies
o Clinical
Research Organizations
o Healthcare Providers
The distinguished
players in the clinical trial management market are Medidata Solutions Inc,
Bio-Optronics Inc, Oracle Corporation, IBM Corporation, Veeva Systems Inc,
Bioclinica Inc, Parexel International Corporation, Advarra (Forte Research
Systems Inc), Arisglobal LLC, and Mednet Solutions Inc.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
SCOPE
2.2. KEY
INSIGHTS
2.2.1. ENTERPRISE-BASED
CTM CONTRIBUTES A MAJOR SHARE IN PRODUCT TYPE SEGMENT
2.2.2. HEALTHCARE
PROVIDERS ARE RAPIDLY GROWING END-USERS IN THE MARKET
2.2.3. SOFTWARE
IS THE LARGEST COMPONENT IN THE CLINICAL TRIAL MANAGEMENT MARKET
2.2.4. CLOUD
MODEL OF DEPLOYMENT IS A PROMISING SEGMENT IN THE MARKET
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE
2.3.3. BARGAINING
POWER OF SUPPLIERS
2.3.4. BARGAINING
POWER OF BUYERS
2.3.5. INTENSITY
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. MARKET
DRIVERS
2.6.1. ALARMING
RISE IN CHRONIC DISEASES
2.6.2. SURGE
IN RESEARCH & DEVELOPMENT IN THE MEDICAL SECTOR
2.6.3. BENEFITS
OFFERED BY CTM SOFTWARE
2.7. MARKET
RESTRAINTS
2.7.1. CONCERNS
REGARDING THE SECURITY OF CTM SYSTEMS
2.7.2. LACK
OF SKILLED WORKFORCE
2.7.3. HIGH
COST OF IMPLEMENTATION
2.8. MARKET
OPPORTUNITIES
2.8.1. GROWTH
IN CLINICAL TRIALS
2.8.2. OUTSOURCING
CLINICAL TRIALS FOR COST REDUCTION
2.9. KEY
STRATEGIC DEVELOPMENTS
2.9.1. MERGER
& ACQUISITIONS
2.9.2. PRODUCT
LAUNCH & DEVELOPMENTS
2.9.3. PARTNERSHIP,
CONTRACT/AGREEMENT, & COLLABORATION
2.10. IMPACT
OF COVID-19 ON THE CLINICAL TRIAL MANAGEMENT MARKET
3. GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY DEPLOYMENT MODE
3.1. WEB-BASED
DEPLOYMENT
3.2. ON-PREMISE
DEPLOYMENT
3.3. CLOUD-BASED
DEPLOYMENT
4. GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY COMPONENT
4.1. SOFTWARE
4.2. HARDWARE
4.3. SERVICES
5. GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY PRODUCT TYPE
5.1. ENTERPRISE-BASED
CTM
5.2. SITE-BASED
CTM
6. GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY END-USER
6.1. PHARMACEUTICAL
& BIOPHARMACEUTICAL COMPANIES
6.2. CLINICAL
RESEARCH ORGANIZATIONS
6.3. HEALTHCARE
PROVIDERS
7. GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET – REGIONAL OUTLOOK
7.1. NORTH
AMERICA
7.1.1. MARKET
BY DEPLOYMENT MODE
7.1.2. MARKET
BY COMPONENT
7.1.3. MARKET
BY PRODUCT TYPE
7.1.4. MARKET
BY END-USER
7.1.5. COUNTRY
ANALYSIS
7.1.5.1. UNITED
STATES
7.1.5.2. CANADA
7.2. EUROPE
7.2.1. MARKET
BY DEPLOYMENT MODE
7.2.2. MARKET
BY COMPONENT
7.2.3. MARKET
BY PRODUCT TYPE
7.2.4. MARKET
BY END-USER
7.2.5. COUNTRY
ANALYSIS
7.2.5.1. UNITED
KINGDOM
7.2.5.2. GERMANY
7.2.5.3. FRANCE
7.2.5.4. SPAIN
7.2.5.5. ITALY
7.2.5.6. RUSSIA
7.2.5.7. REST
OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. MARKET
BY DEPLOYMENT MODE
7.3.2. MARKET
BY COMPONENT
7.3.3. MARKET
BY PRODUCT TYPE
7.3.4. MARKET
BY END-USER
7.3.5. COUNTRY
ANALYSIS
7.3.5.1. CHINA
7.3.5.2. JAPAN
7.3.5.3. INDIA
7.3.5.4. SOUTH
KOREA
7.3.5.5. ASEAN
COUNTRIES
7.3.5.6. AUSTRALIA
& NEW ZEALAND
7.3.5.7. REST
OF ASIA-PACIFIC
7.4. LATIN
AMERICA
7.4.1. MARKET
BY DEPLOYMENT MODE
7.4.2. MARKET
BY COMPONENT
7.4.3. MARKET
BY PRODUCT TYPE
7.4.4. MARKET
BY END-USER
7.4.5. COUNTRY
ANALYSIS
7.4.5.1. BRAZIL
7.4.5.2. MEXICO
7.4.5.3. REST
OF LATIN AMERICA
7.5. MIDDLE
EAST AND AFRICA
7.5.1. MARKET
BY DEPLOYMENT MODE
7.5.2. MARKET
BY COMPONENT
7.5.3. MARKET
BY PRODUCT TYPE
7.5.4. MARKET
BY END-USER
7.5.5. COUNTRY
ANALYSIS
7.5.5.1. UNITED
ARAB EMIRATES
7.5.5.2. TURKEY
7.5.5.3. SAUDI
ARABIA
7.5.5.4. SOUTH
AFRICA
7.5.5.5. REST
OF MIDDLE EAST & AFRICA
8. COMPETITIVE
LANDSCAPE
8.1. MEDIDATA
SOLUTIONS INC
8.2. ARISGLOBAL
LLC
8.3. BIOCLINICA
INC
8.4. BIO-OPTRONICS
INC
8.5. ADVARRA
(FORTE RESEARCH SYSTEMS INC)
8.6. ORACLE
CORPORATION
8.7. IBM
CORPORATION
8.8. MEDNET
SOLUTIONS INC
8.9. PAREXEL
INTERNATIONAL CORPORATION
8.10. VEEVA
SYSTEMS INC
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET, BY GEOGRAPHY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR
SCORECARD
TABLE 3: GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2021-2028 (IN $ MILLION)
TABLE 4: GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, 2021-2028 (IN $ MILLION)
TABLE 5: GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2028 (IN $ MILLION)
TABLE 6: GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 7: GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET, BY GEOGRAPHY, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2021-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, 2021-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 13: EUROPE
CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 14: EUROPE
CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2021-2028 (IN $ MILLION)
TABLE 15: EUROPE
CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, 2021-2028 (IN $ MILLION)
TABLE 16: EUROPE
CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2028 (IN $ MILLION)
TABLE 17: EUROPE
CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 18: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 19: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2021-2028 (IN $ MILLION)
TABLE 20: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, 2021-2028 (IN $ MILLION)
TABLE 21: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2028 (IN $ MILLION)
TABLE 22: ASIA-PACIFIC
CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 23: LATIN AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 24: LATIN AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2021-2028 (IN $ MILLION)
TABLE 25: LATIN AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, 2021-2028 (IN $ MILLION)
TABLE 26: LATIN AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2028 (IN $ MILLION)
TABLE 27: LATIN AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 28: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2021-2028 (IN $
MILLION)
TABLE 29: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2021-2028 (IN
$ MILLION)
TABLE 30: MIDDLE EAST
AND AFRICA TRIAL MANAGEMENT MARKET, BY COMPONENT, 2021-2028 (IN $ MILLION)
TABLE 31: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2028 (IN $
MILLION)
TABLE 32: MIDDLE EAST
AND AFRICA CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, 2021-2028 (IN $
MILLION)
FIGURE 1: GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2020 & 2028 (IN %)
FIGURE 2: PORTER’S FIVE
FORCES ANALYSIS
FIGURE 3: MARKET
ATTRACTIVENESS INDEX
FIGURE 4: GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET, BY WEB-BASED DEPLOYMENT, 2021-2028 (IN $
MILLION)
FIGURE 5: GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET, BY ON-PREMISE DEPLOYMENT, 2021-2028 (IN $
MILLION)
FIGURE 6: GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET, BY CLOUD-BASED DEPLOYMENT, 2021-2028 (IN $
MILLION)
FIGURE 7: GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET, BY SOFTWARE, 2021-2028 (IN $ MILLION)
FIGURE 8: GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET, BY HARDWARE, 2021-2028 (IN $ MILLION)
FIGURE 9: GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET, BY SERVICES, 2021-2028 (IN $ MILLION)
FIGURE 10: GLOBAL CLINICAL
TRIAL MANAGEMENT MARKET, BY ENTERPRISE-BASED CTM, 2021-2028 (IN $ MILLION)
FIGURE 11: GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET, BY SITE-BASED CTM, 2021-2028 (IN $ MILLION)
FIGURE 12: GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL
COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 13: GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET, BY CLINICAL RESEARCH ORGANIZATIONS, 2021-2028
(IN $ MILLION)
FIGURE 14: GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET, BY HEALTHCARE PROVIDERS, 2021-2028 (IN $
MILLION)
FIGURE 15: GLOBAL
CLINICAL TRIAL MANAGEMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 16: UNITED
STATES CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 17: CANADA
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 18: UNITED
KINGDOM CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 19: GERMANY
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 20: FRANCE
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 21: SPAIN
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 22: ITALY
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: RUSSIA
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: REST OF
EUROPE CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 25: CHINA
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: JAPAN
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: INDIA
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: SOUTH KOREA
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 29: ASEAN
COUNTRIES CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 30: AUSTRALIA
& NEW ZEALAND CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 31: REST OF
ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 32: BRAZIL
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 33: MEXICO
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 34: REST OF
LATIN AMERICA CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 35: UNITED ARAB
EMIRATES CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 36: TURKEY
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 37: SAUDI ARABIA
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 38: SOUTH AFRICA
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 39: REST OF
MIDDLE EAST & AFRICA CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $
MILLION)